HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control

	HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
发表期刊	MOLECULAR THERAPY-NUCLEIC ACIDS
	2018
卷号	13 页码:208-219
	Zhao C(赵晨); Yingze Zhao; Jingfang Zhang; Jia Lu; Li Chen; Yue Zhang; Yue Ying; Junjun Xu; Shixian Wei; Wang Y(王宇)
文献类型	期刊论文
条目标识符	http://ir.ioz.ac.cn/handle/000000/13471
专题	干细胞与生殖生物学国家重点实验室
推荐引用方式 GB/T 7714	Zhao C,Yingze Zhao,Jingfang Zhang,et al. HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control[J]. MOLECULAR THERAPY-NUCLEIC ACIDS,2018,13:208-219.
APA	赵晨.,Yingze Zhao.,Jingfang Zhang.,Jia Lu.,Li Chen.,...&王宇.(2018).HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control.MOLECULAR THERAPY-NUCLEIC ACIDS,13,208-219.
MLA	赵晨,et al."HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control".MOLECULAR THERAPY-NUCLEIC ACIDS 13(2018):208-219.